232 related articles for article (PubMed ID: 30885433)
41. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
[TBL] [Abstract][Full Text] [Related]
42. E6 hijacks KDM5C/lnc_000231/miR-497-5p/CCNE1 axis to promote cervical cancer progression.
Zhang Y; Li X; Zhang J; Mao L
J Cell Mol Med; 2020 Oct; 24(19):11422-11433. PubMed ID: 32818316
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin.
Liu Y; Lin J; Zhai S; Sun C; Xu C; Zhou H; Liu H
Cell Physiol Biochem; 2018; 45(4):1654-1662. PubMed ID: 29486472
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA circSEMA5A facilitates colorectal cancer development by regulating microRNA-195-5p to target CCNE1 axis.
Ye Q; Liu S; Lin S; Xie W
Cell Signal; 2023 Jul; 107():110649. PubMed ID: 37164546
[TBL] [Abstract][Full Text] [Related]
45. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
47. Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition.
Au-Yeung G; Lang F; Azar WJ; Mitchell C; Jarman KE; Lackovic K; Aziz D; Cullinane C; Pearson RB; Mileshkin L; Rischin D; Karst AM; Drapkin R; Etemadmoghadam D; Bowtell DD
Clin Cancer Res; 2017 Apr; 23(7):1862-1874. PubMed ID: 27663592
[No Abstract] [Full Text] [Related]
48. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.
Yang W; Gu J; Wang X; Wang Y; Feng M; Zhou D; Guo J; Zhou M
J Cell Mol Med; 2019 May; 23(5):3166-3177. PubMed ID: 30884120
[TBL] [Abstract][Full Text] [Related]
50. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.
Cocco E; Lopez S; Black J; Bellone S; Bonazzoli E; Predolini F; Ferrari F; Schwab CL; Menderes G; Zammataro L; Buza N; Hui P; Wong S; Zhao S; Bai Y; Rimm DL; Ratner E; Litkouhi B; Silasi DA; Azodi M; Schwartz PE; Santin AD
Br J Cancer; 2016 Jul; 115(3):303-11. PubMed ID: 27351214
[TBL] [Abstract][Full Text] [Related]
51. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
[TBL] [Abstract][Full Text] [Related]
53. A novel long non-coding RNA LINC00355 promotes proliferation of lung adenocarcinoma cells by down-regulating miR-195 and up-regulating the expression of CCNE1.
Liang Y; Rong X; Luo Y; Li P; Han Q; Wei L; Wang E
Cell Signal; 2020 Feb; 66():109462. PubMed ID: 31689506
[TBL] [Abstract][Full Text] [Related]
54. Ectopic expression of microRNA-874 represses epithelial mesenchymal transition through the NF-κB pathway via CCNE1 in cholangiocarcinoma.
Pan X; Wang G; Wang B
Cell Signal; 2021 Jun; 82():109927. PubMed ID: 33476715
[TBL] [Abstract][Full Text] [Related]
55. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
56. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression.
Li L; Xie K; Xie H; Wang L; Li Z; Lu Q; Feng J
Aging (Albany NY); 2024 May; 16(9):8019-8030. PubMed ID: 38713155
[TBL] [Abstract][Full Text] [Related]
57. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
59. CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
[TBL] [Abstract][Full Text] [Related]
60. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.
Liang Y; Zhang D; Li L; Xin T; Zhao Y; Ma R; Du J
Stem Cell Res Ther; 2020 Feb; 11(1):87. PubMed ID: 32102682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]